We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells

This study has been withdrawn prior to enrollment.
(This study was not feasible due to facility budget and contractual issues.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01173510
First Posted: August 2, 2010
Last Update Posted: June 14, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Community Research Initiative of New England
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: October 19, 2012
  Primary Completion Date: October 19, 2012 (Final data collection date for primary outcome measure)